It took 27 years, but Cytokinetics secured its first U.S. drug approval. On Friday, the Food and Drug Administration cleared ...

Adding another potential wrinkle to the industry’s work with China is the Biosecure Act, a piece of China-targeting national ...

On December 19, 2025, the National Security Commission on Emerging Biotechnology (NSCEB) announced the publication of a paper entitled “The Future of U.S.-China Biotechnology Competition.” The paper ...

KKR's 2026 Outlook finds value beyond the S&P 500. Explore investment strategies in Asia, biotech, and critical infrastructure.

TrinScreen HIV order signals renewed strength in global HIV testing market - Company also reports a key milestone of Adjusted EBITDA(1) positive operations in Q3 2025 and expects to achieve strong ...

Norgine, a leading European specialty pharmaceutical company, today announced an exclusive licensing agreement under which ...

MAIA Biotechnology (MAIA) announced that independent directors including Adelina Louie Ngar Yee and Stan Smith, purchased common stock and ...

Lixte Biotechnology Holdings ( ($LIXT) ) has shared an announcement. On December 18, 2025, Lixte Biotechnology Holdings, Inc. entered into ...

Discover how intellectual property rights protect exclusive pharmaceutical use and brand names in biotechnology, influencing innovation and market dynamics.

James B. Hunt Jr., a populist four-term governor who championed biotechnology as a new economic engine for North Carolina and ...